The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

21 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Fragment-Based Discovery of 2-Aminoquinazolin-4(3H)-ones As Novel Class Nonpeptidomimetic Inhibitors of the Plasmepsins I, II, and IV.EBI
Latvian Institute of Organic Synthesis
Substrate derived peptidica-ketoamides as inhibitors of the malarial protease PfSUB1.EBI
Latvian Institute of Organic Synthesis
6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells.EBI
Latvian Institute of Organic Synthesis
Synthesis of 6-aryl-substituted sulfocoumarins and investigation of their carbonic anhydrase inhibitory action.EBI
Latvian Institute of Organic Synthesis
Synthesis and evaluation of (E)-2-(acrylamido)cyclohex-1-enecarboxylic acid derivatives as HCA1, HCA2, and HCA3 receptor agonists.EBI
Latvian Institute of Organic Synthesis
Plasmepsin inhibitory activity and structure-guided optimization of a potent hydroxyethylamine-based antimalarial hit.EBI
Latvian Institute of Organic Synthesis
Pyrazolidinone-based peptidomimetic SARS-CoV-2 MEBI
Latvian Institute of Organic Synthesis
Macrocyclic Peptidomimetic Plasmepsin X Inhibitors with Potent EBI
Latvian Institute of Organic Synthesis
Discovery of Malarial Threonyl tRNA Synthetase Inhibitors by Screening of a Focused Fragment Library.EBI
Latvian Institute of Organic Synthesis
Atropo/Tropo Flexibility: A Tool for Design and Synthesis of Self-Adaptable Inhibitors of Carbonic Anhydrases and Their Antiproliferative Effect.EBI
Latvian Institute of Organic Synthesis
Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery.EBI
Latvian Institute of Organic Synthesis
Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.EBI
Latvian Institute of Organic Synthesis
Development of oxathiino[6,5-b]pyridine 2,2-dioxide derivatives as selective inhibitors of tumor-related carbonic anhydrases IX and XII.EBI
Latvian Institute of Organic Synthesis
Benzoxepinones: A new isoform-selective class of tumor associated carbonic anhydrase inhibitors.EBI
Latvian Institute of Organic Synthesis
Exploiting Structural Dynamics To Design Open-Flap Inhibitors of Malarial Aspartic Proteases.EBI
Latvian Institute of Organic Synthesis
Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D.EBI
Latvian Institute of Organic Synthesis
6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII.EBI
Latvian Institute of Organic Synthesis
Synthesis of 6-tetrazolyl-substituted sulfocoumarins acting as highly potent and selective inhibitors of the tumor-associated carbonic anhydrase isoforms IX and XII.EBI
Latvian Institute of Organic Synthesis
2-Aminoquinazolin-4(3H)-one based plasmepsin inhibitors with improved hydrophilicity and selectivity.EBI
Latvian Institute of Organic Synthesis
Synthesis and evaluation of (E)-2-(5-phenylpent-2-en-4-ynamido)cyclohex-1-ene-1-carboxylate derivatives as HCA2 receptor agonists.EBI
Latvian Institute of Organic Synthesis
N-Substituted and ring opened saccharin derivatives selectively inhibit transmembrane, tumor-associated carbonic anhydrases IX and XII.EBI
Latvian Institute of Organic Synthesis